Meaning
Laboratory assessment protocols quantify the chemical fraction released from an ingested matrix into digestive fluids that becomes available for intestinal absorption. Food packaging compliance and polymer toxicology programmes employ bioaccessibility bioassays to determine the systemic exposure risk of additives, heavy metal pigments, catalysts and degradation products from plastic particles. The protocol subjects polymers to synthetic saliva, gastric juice and intestinal fluids maintained at physiological temperature.
Measurements capture the mass fraction of migrant dissolved into digestive fluids rather than the total chemical load embedded inside the polymer bulk. Migration ceases once chemical equilibrium between the solid polymer and the liquid digestive matrix occurs. These assays establish the true extractable hazard of recycled resins without requiring live animal testing models.
In Vitro Digestion
Controlled biochemical extraction chambers simulate human gastrointestinal passage across sequential digestive compartments. Solid polymer flakes, regrind fragments or shredded film samples enter bioaccessibility bioassays to trace the chemical desorption of internal slip agents, antioxidants and plasticisers under digestive conditions. The test exposes polymer specimens to synthetic oral fluids containing amylase, transfers the material into an acidic gastric environment with pepsin, and concludes in a neutral intestinal compartment containing bile salts and pancreatin.
Mechanical shaking reproduces peristaltic fluid shear, sweeping additives away from the plastic surface. Dissolution kinetics depend on temperature, residence time, liquid agitation and additive molecular weight. Fluid filtration separates suspended polymer particles from the clarified aqueous digest, permitting precise chromatographic analysis of the bioaccessible chemical fraction.
Toxicological Screening
Virgin and post-consumer plastics exhibit drastically different desorption profiles during digestive simulation. Recycled food contact articles derived from mechanically processed polyethylene terephthalate or high-density polyethylene may harbour non-intentionally added substances, ink solvents or consumer misuse residues. Running bioaccessibility bioassays on candidate resin lots isolates the chemical fraction capable of permeating the human gut wall, separating inert encapsulated contaminants from biologically available toxins.
Heavy metal stabilisers like lead or cadmium bound within rigid polyvinyl chloride matrices demonstrate negligible bioaccessibility under neutral conditions, but trace amounts leach under gastric acidity. High bioaccessible fractions indicate that a plastic formulation presents migration risks regardless of total chemical concentration inside the resin. Sourcing teams use these analytical yields to reject suspect recycled resin lots before initiating commercial tooling trials.
Analytical Boundary
Digestion bioassays isolate the dissolved chemical fraction but cannot measure internal cellular uptake or cellular toxicity across intestinal epithelial membranes. The bioaccessible value generated by bioaccessibility bioassays reflects an upper thermodynamic limit of what could cross the gut barrier into systemic circulation. Polymeric particles that undergo enzymatic cleavage, such as biodegradable polylactic acid or starch blends, change surface morphology during digestion, which releases embedded additives faster than inert polyolefin matrices.
In contrast, non-degradable resins retain their bulk volume, restricting additive release strictly to diffusion through the solid polymer skin. Testing protocols must account for plastic particle size distribution, because fine microplastic powders yield higher bioaccessible fractions than standard commercial pellets. Bioaccessible fraction calculations establish the baseline chemical dosage for human health risk assessments of polymer packaging.